Richard A. Fair
2019
In 2019, Richard A. Fair earned a total compensation of $1.7M as President and Chief Executive Officer at BELLICUM PHARMACEUTICALS, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $127,990 |
|---|---|
| Option Awards | $1,021,004 |
| Salary | $566,204 |
| Other | $17,690 |
| Total | $1,732,888 |
Fair received $1M in option awards, accounting for 59% of the total pay in 2019.
Fair also received $128K in non-equity incentive plan, $566.2K in salary and $17.7K in other compensation.
Rankings
In 2019, Richard A. Fair's compensation ranked 6,628th out of 13,971 executives tracked by ExecPay. In other words, Fair earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,628 out of 13,971 | 53rd |
Division Manufacturing | 2,518 out of 5,701 | 56th |
Major group Chemicals And Allied Products | 915 out of 2,200 | 58th |
Industry group Drugs | 773 out of 1,886 | 59th |
Industry Pharmaceutical Preparations | 568 out of 1,398 | 59th |
Source: SEC filing on April 27, 2020.
Fair's colleagues
We found three more compensation records of executives who worked with Richard A. Fair at BELLICUM PHARMACEUTICALS in 2019.